Bioplaster: Fakta och siffror 1
FAQ JUN 2017 European Bioplastics e.V. Marienstr.
19/20 10117 Berlin Can a sufficient supply of bioplastics be guaranteed? Supply is well ensured to meet the growing demand in the short and medium term. However, it is difficult to make long-term forecasts due to the dynamic and innovative nature of the bioplastic market. A reliable legislative framework in the EU would be beneficial to further attract investment and ensure supply in the long run. In recent years, numerous joint ventures have been established and planned investments in bioplastic production capacities have been made. Initial facilities producing various types of bioplastics are operating in Europe, the Americas and Asia. Additional facilities and biorefineries are currently being set up in different regions from Italy to Thailand to produce bioplastics, including starch compounds, PLA, bio-based PBS, bio-based PE, bio-based PET, or PEF. These investments and scale-ups are reflected in European Bioplastics’ market data, which show growth in capacity from 4.2 million tons in 2016 to roughly 6.1 million tons in 2021. http://www.european-bioplastics.org/market/ Can fossil-based plastics be completely substituted by bio-based bioplastics? Today, there is pretty much nothing that bioplastics can’t do. For almost every conventional plastic material and application, there is a bioplastic alternative available that offers the same or in some cases even better properties and functionalities. The main challenge faced by the bioplastics industry is not of technical nature but the lack of effective policy measures or regulatory incentives to encourage a full-scale market entry. According to a PRO BIP study conducted by the University of Utrecht in 2009, bioplastics could technically substitute around 85 percent of conventional plastics. To make all plastics from bio-based materials is not a realistic short- or mid-term development. http://www.european-bioplastics.org/market/ What are the economic advantages of bioplastics? As an important part of the bioeconomy, bioplastics are a future lead market for the European Union offering job creation, development of rural areas and global export opportunities for innovative technologies. According to a recent job market analysis conducted by EuropaBio, the European bioplastics industry could realise a steep employment growth over the next decades. In 2013, the bioplastics industry accounted for around 23,000 jobs in Europe. With the right framework conditions in place, this number could increase more than tenfold by 2030, with up to 300,000 high-skilled jobs being created in the European bioplastics sector. phone fax European Bioplastics e.V. The European bioeconomy sectors are worth 2 trillion euros in annual turnover and account for 22 million jobs in the EU. That is approx. 9 percent of the EU’s workforce. e-mail web Marienstr. 19/20, 10117 Berlin +49.30.28 48 23 50 +49.30.28 48 23 59 email@example.com www.european-bioplastics.org http://www.european-bioplastics.org/market/ How many people are employed in the European bioplastics industry today? In 2013, the bioplastics industry accounted for 23,000 jobs in Europe. With the right framework conditions in place, this number could increase more than tenfold by 2030, with up to 300,000 high-skilled jobs being created in the European bioplastics sector. http://www.european-bioplastics.org/market/market-drivers/ How many jobs could be created in the bioplastics industry in Europe until 2030? With the right legislative framework and market conditions in place, the European bioplastics industry could offer an immense employment growth potential. From 23,000 employees in 2013, the bioplastics industry could grow to 300,000 high-skilled jobs in 2030. The bioplastics industry could provide new impulses for the development of rural areas in Europe by presenting new opportunities for the agricultural sector and consequently contribute to the reindustrialisation and employment growth in Europe. Feasibility studies showed that bioplastics could technically substitute about 85 percent of all conventional plastics (according to PRO BIP study conducted by the University of Utrecht in 2009), even though this is not a realistic short- or mid-term development, it illustrates that bioplastics will be a significant part of the overall plastics market in the future. http://www.european-bioplastics.org/market/market-drivers/ Are bioplastics more expensive then conventional plastics? The cost of research and development still makes up for a share of investment in bioplastics and has an impact on material and product prices. Additionally, the currently low oil prices are making it difficult for bioplastics to achieve competitive pricing levels compared to conventional plastics at present. However, prices have continuously been decreasing over the past decade. As more companies and brands are switching to bio-based plastics, and as production capacities are rising, supply chains and processes are becoming more efficient, and prices have come down significantly. With rising demand and more efficient production processes, increasing volumes of bioplastics on the market and oil prices expected to rise again, the costs for bioplastics will soon be comparable with those for conventional plastic prices. VR 19997 Nz, Amtsgericht Charlottenburg, USt-IdNr. DE235874231 HypoVereinsbank Rosenheim, BLZ 711 200 77, Konto 6356800, IBAN DE26 7112 0077 0006 3568 00, BIC/SWIFT HYVEDEMM448 7